Literature DB >> 19901249

Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum.

R Migliaccio1, F Agosta, K Rascovsky, A Karydas, S Bonasera, G D Rabinovici, B L Miller, M L Gorno-Tempini.   

Abstract

OBJECTIVE: Posterior cortical atrophy (PCA) and logopenic progressive aphasia (LPA) are clinical syndromes associated with posterior brain atrophy. We compared PCA and LPA to each other and to an age-matched group of patients with early age at onset of Alzheimer disease (EO-AD). We hypothesized that these 3 syndromes are part of a single clinical and biologic continuum.
METHODS: Voxel-based morphometry (VBM) was used to assess atrophy in 14 PCA, 10 LPA, and 16 EO-AD patients compared to 65 healthy controls. Genetic analysis for APOE was conducted in 30 patients and 44 controls. Four patients came to autopsy. An additional 14 were studied with the beta-amyloid specific PET with tracer (11)C-labeled Pittsburgh Compound-B (PIB).
RESULTS: VBM results demonstrated that, compared to controls, each patient group showed a large area of overlapping atrophy in bilateral parietal, occipital, precuneus, posterior cingulate, posterior temporal, and hippocampal regions. Surrounding this common area, group-specific atrophy was found in small, symptom-specific regions for each group: the right ventral-occipital and superior parietal regions in PCA, the left middle and superior temporal gyri in LPA, and the prefrontal cortex in EO-AD. APOE epsilon4 frequency was higher in all patient groups compared to controls. Four PCA, 5 LPA, and 8 EO-AD patients showed evidence of cortical amyloid at pathology (n = 3) or on PIB-PET (n = 14).
CONCLUSIONS: Logopenic progressive aphasia and posterior cortical atrophy showed largely overlapping anatomic and biologic features with early age at onset of Alzheimer disease, suggesting that these clinical syndromes represent the spectrum of clinical manifestation of the nontypical form of Alzheimer disease that presents at an early age.

Entities:  

Mesh:

Year:  2009        PMID: 19901249      PMCID: PMC2777069          DOI: 10.1212/WNL.0b013e3181c0d427

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  Neurodegenerative diseases target large-scale human brain networks.

Authors:  William W Seeley; Richard K Crawford; Juan Zhou; Bruce L Miller; Michael D Greicius
Journal:  Neuron       Date:  2009-04-16       Impact factor: 17.173

2.  Neuropsychological performance in early and late onset Alzheimer's disease: comparisons in a memory clinic population.

Authors:  Srinivas Suribhatla; Sarah Baillon; Michael Dennis; Mangesh Marudkar; Saquib Muhammad; Dena Munro; Christine Spreadbury; James Lindesay
Journal:  Int J Geriatr Psychiatry       Date:  2004-12       Impact factor: 3.485

Review 3.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

4.  Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type.

Authors:  J V Haxby; C L Grady; E Koss; B Horwitz; L Heston; M Schapiro; R P Friedland; S I Rapoport
Journal:  Arch Neurol       Date:  1990-07

5.  Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease.

Authors:  Joel H Kramer; Jennifer Jurik; Sharon J Sha; Kate P Rankin; Howard J Rosen; Julene K Johnson; Bruce L Miller
Journal:  Cogn Behav Neurol       Date:  2003-12       Impact factor: 1.600

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy.

Authors:  D F Tang-Wai; N R Graff-Radford; B F Boeve; D W Dickson; J E Parisi; R Crook; R J Caselli; D S Knopman; R C Petersen
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

8.  Cognition and anatomy in three variants of primary progressive aphasia.

Authors:  Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

9.  Towards a behavioral typology of Alzheimer's patients.

Authors:  A Martin; P Brouwers; F Lalonde; C Cox; P Teleska; P Fedio; N L Foster; T N Chase
Journal:  J Clin Exp Neuropsychol       Date:  1986-10       Impact factor: 2.475

10.  Posterior cortical atrophy.

Authors:  D F Benson; R J Davis; B D Snyder
Journal:  Arch Neurol       Date:  1988-07
View more
  98 in total

Review 1.  Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.

Authors:  William E Klunk
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Ventral and dorsal visual streams in posterior cortical atrophy: a DT MRI study.

Authors:  Raffaella Migliaccio; Federica Agosta; Elisa Scola; Giuseppe Magnani; Stefano F Cappa; Elisabetta Pagani; Elisa Canu; Giancarlo Comi; Andrea Falini; Maria Luisa Gorno-Tempini; Paolo Bartolomeo; Massimo Filippi
Journal:  Neurobiol Aging       Date:  2012-01-24       Impact factor: 4.673

3.  Treatment of a patient with posterior cortical atrophy (PCA) with chiropractic manipulation and Dynamic Neuromuscular Stabilization (DNS): A case report.

Authors:  Vinicius T Francio; Ron Boesch; Michael Tunning
Journal:  J Can Chiropr Assoc       Date:  2015-03

Review 4.  Towards a clearer definition of logopenic progressive aphasia.

Authors:  Cristian E Leyton; John R Hodges
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

5.  Clinicopathological correlations in corticobasal degeneration.

Authors:  Suzee E Lee; Gil D Rabinovici; Mary Catherine Mayo; Stephen M Wilson; William W Seeley; Stephen J DeArmond; Eric J Huang; John Q Trojanowski; Matthew E Growdon; Jung Y Jang; Manu Sidhu; Tricia M See; Anna M Karydas; Maria-Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; Michael D Geschwind; Katherine P Rankin; Bruce L Miller
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

6.  Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.

Authors:  Rik Ossenkoppele; Niklas Mattsson; Charlotte E Teunissen; Frederik Barkhof; Yolande Pijnenburg; Philip Scheltens; Wiesje M van der Flier; Gil D Rabinovici
Journal:  Neurobiol Aging       Date:  2015-04-25       Impact factor: 4.673

7.  Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.

Authors:  Raffaella Migliaccio; Federica Agosta; Katherine L Possin; Elisa Canu; Massimo Filippi; Gil D Rabinovici; Howard J Rosen; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Non-pharmacological intervention for posterior cortical atrophy.

Authors:  Agnès Weill-Chounlamountry; Jorge Alves; Pascale Pradat-Diehl
Journal:  World J Clin Cases       Date:  2016-08-16       Impact factor: 1.337

Review 9.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 10.  Posterior Cortical Atrophy.

Authors:  Jonathan M Schott; Sebastian J Crutch
Journal:  Continuum (Minneap Minn)       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.